Integration of Virtual Reality Mindfulness Application Within a Mobile-Based Recovery Platform to Support Rehab and Post-Rehab Engagement
将虚拟现实正念应用程序集成到基于移动的恢复平台中,以支持康复和康复后参与
基本信息
- 批准号:10353420
- 负责人:
- 金额:$ 66.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-30 至 2023-01-31
- 项目状态:已结题
- 来源:
- 关键词:AftercareAlcohol dependenceAlcoholsAndroidCaringCellular PhoneClinicClinicalCommunitiesCoupledDevelopmentDrug AddictionEnhancement TechnologyFeedbackFocus GroupsHealthHealth Services AccessibilityHealthcare SystemsHomeHome environmentImmersionIndividualInformal Social ControlInpatientsInterventionMedical DeviceMental HealthMethodsMissionOpioidOutcomeParticipantPatientsPersonal SatisfactionPersonsPhasePopulationPreparationProductionProtocols documentationRandomizedRecoveryRecovery SupportRelapseResearchResourcesScientistServicesStimulantStructureSubstance Use DisorderTechnologyTestingTherapeuticTherapeutic EffectTimeTrainingTraining SupportTreatment EfficacyUniversitiesVisualWell in selfacceptability and feasibilityaddictionbasecostcost effectivedesignevidence baseexperiencefeasibility testingimprovedinnovationinpatient servicemachine learning algorithmmembermindfulnessmindfulness interventionmobile applicationnew technologypeerpeer coachingpeer supportpilot testprototyperelapse predictionrelapse risksobrietysocialsound frequencysubstance usesubstance use treatmentsuccesstelehealththerapy designtreatment as usualtreatment programtreatment researchvirtual reality
项目摘要
ABSTRACT
Post-treatment substance use disorder (SUD) relapse rates are high (40-60% at one year), with relapse
occurring early (median time to relapse 1-3 months), indicating that the transition period from inpatient care to
the home environment is particularly challenging for patients seeking sobriety. Telehealth and VR technologies
have the ability to greatly increase the accessibility of highly engaging recovery support. Combining these two
approaches provides a unique opportunity to create a highly engaging, cost-effective take home recovery support
solution targeting the critical transition from inpatient care.
Sober Grid proposes to leverage its existing highly accessible social and peer coaching mobile recovery app, to
develop a convenient and cost-effective integrated take-home combined VR and professional peer coaching
recovery support intervention (RecoVRi) that begins in the inpatient clinic. RecoVRi is designed to increase
engagement with recovery therapy during the critical transition from inpatient to home, thereby reducing the risk
of relapse and associated health and monetary costs. Sober Grid is collaborating with TRIPP, Inc. to utilize
TRIPP’s immersive wellness platform. The design of the TRIPP experience leverages a large body of existing
research on the use of VR technology in the mental wellness arena and utilizes proven mindfulness structures,
targeted sound frequencies, visuals and interactions that have a multiplicative effect when administered through
immersion. The Sober Grid Network will create a support wrapper to the VR experience that facilitates access to
crisis management experts and community for the person in early recovery. The unique combination of a
personalized and targeted self-regulation toolkit and community and professional support is a key differentiator
for this service.
In phase I of the project, we will develop and pilot test a proof-of-concept RecoVRi VR-mindfulness protocol and
intervention to ascertain feasibility and acceptability (Aim 1). In phase II of the project, a production-quality
intervention will be developed with new VR content created by the TRIPP development team specifically
targeting themes supporting recovery from alcohol, stimulant and opioid SUD separately (Aim 2). We will then
test post-treatment recovery support engagement in the RecoVRi intervention in comparison to treatment as
usual in a randomized comparison trial involving 80 patients receiving inpatient treatment and transitioning to
the home setting (Aim 3). Over the span of both phases, we will seek regulatory guidance from the FDA in order
to attain clearance for use of the RecoVRi intervention as a therapeutic medical device (Aim 4).
摘要
治疗后物质使用障碍(SUD)复发率很高(一年为40%-60%),并有复发
发生较早(复发的中位时间为1-3个月),表明从住院治疗到
对于寻求戒酒的患者来说,家庭环境尤其具有挑战性。远程医疗和虚拟现实技术
有能力极大地提高高度参与的恢复支持的可及性。将这两者结合起来
Approach提供了一个独特的机会来创建极具吸引力、经济高效的带回家的恢复支持
针对住院护理的关键过渡的解决方案。
Sober Grid建议利用其现有的高度可访问的社交和同伴辅导移动恢复应用程序,以
开发一种方便且经济实惠的综合带回家的虚拟现实和专业同伴辅导
从住院诊所开始的康复支持干预(RecoVRi)。RecoVRi旨在提高
在从住院到家庭的关键过渡期间参与康复治疗,从而降低风险
复发以及相关的健康和货币成本。清醒网格公司正在与Tripp,Inc.合作利用
Tripp的身临其境的健康平台。Tripp体验的设计利用了大量现有的
研究虚拟现实技术在精神健康领域的应用,并利用经过验证的正念结构,
有针对性的声音频率、视觉效果和相互作用,当通过
沉浸其中。Sober Grid Network将创建VR体验的支持包装,以便于访问
危机管理专家和社会各界为早期康复的人。独一无二的组合
个性化和针对性的自律工具包以及社区和专业支持是一个关键优势
为这项服务。
在项目的第一阶段,我们将开发和试点测试概念验证RecoVRi VR正念协议,并
采取干预措施,以确定可行性和可接受性(目标1)。在项目的第二阶段,一个生产质量
干预将使用Tripp开发团队专门创建的新VR内容进行开发
针对分别支持戒除酒精、兴奋剂和阿片类药物的主题(目标2)。到时候我们会的
测试RecoVRi干预与AS治疗的治疗后恢复支持参与度
通常在一项随机对照试验中,涉及80名接受住院治疗并过渡到
主场环境(目标3)。在这两个阶段,我们将寻求FDA的监管指导,以
获得将RecoVRi干预用作治疗性医疗设备的许可(目标4)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Wendy Warrington其他文献
Wendy Warrington的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Wendy Warrington', 18)}}的其他基金
Integration of Virtual Reality Mindfulness Application Within a Mobile-Based Recovery Platform to Support Rehab and Post-Rehab Engagement
将虚拟现实正念应用程序集成到基于移动的恢复平台中,以支持康复和康复后参与
- 批准号:
10209530 - 财政年份:2019
- 资助金额:
$ 66.71万 - 项目类别:
LEVERAGING PREDICTIVE ANALYTICS WITHIN SOCIAL NETWORKS TO MAXIMIZE DRUG ANDALCOHOL TREATMENT EFFICACY AND RELAPSE PREVENTION
利用社交网络内的预测分析最大限度地提高药物和酒精治疗的功效并预防复发
- 批准号:
9897501 - 财政年份:2017
- 资助金额:
$ 66.71万 - 项目类别:
相似海外基金
Role of glucocorticoid receptor-mediated mRNA decay in alcohol dependence
糖皮质激素受体介导的 mRNA 衰减在酒精依赖中的作用
- 批准号:
10811212 - 财政年份:2023
- 资助金额:
$ 66.71万 - 项目类别:
6/11 Astrocyte-specific changes and interventions in alcohol dependence
6/11 星形胶质细胞特异性变化和酒精依赖干预
- 批准号:
10591606 - 财政年份:2022
- 资助金额:
$ 66.71万 - 项目类别:
An Investigation of Reward Processing in Co-occurring Alcohol Dependence and Loss of Control Eating
对同时发生的酒精依赖和饮食失控的奖励处理的研究
- 批准号:
486597 - 财政年份:2022
- 资助金额:
$ 66.71万 - 项目类别:
Studentship Programs
Identifying new targets for the treatment of alcohol dependence and relapse: epigenetic analysis of the abstinent brain
确定治疗酒精依赖和复发的新靶点:戒酒大脑的表观遗传学分析
- 批准号:
10396660 - 财政年份:2022
- 资助金额:
$ 66.71万 - 项目类别:
Identifying new targets for the treatment of alcohol dependence and relapse: epigenetic analysis of the abstinent brain
确定治疗酒精依赖和复发的新靶点:戒酒大脑的表观遗传学分析
- 批准号:
10553449 - 财政年份:2022
- 资助金额:
$ 66.71万 - 项目类别:
6/11 Astrocyte-specific changes and interventions in alcohol dependence
6/11 星形胶质细胞特异性变化和酒精依赖干预
- 批准号:
10409263 - 财政年份:2022
- 资助金额:
$ 66.71万 - 项目类别:
Novel GLT-1 activators for the treatment of alcohol dependence: preclinical studies
用于治疗酒精依赖的新型 GLT-1 激活剂:临床前研究
- 批准号:
10517529 - 财政年份:2022
- 资助金额:
$ 66.71万 - 项目类别:
Reducing alcohol-seeking behavior in a rat model of alcohol dependence
减少酒精依赖大鼠模型的寻酒行为
- 批准号:
10684236 - 财政年份:2022
- 资助金额:
$ 66.71万 - 项目类别:
Opposing Contributions of Oxytocin and Corticotropin-Release Factor to Alcohol Dependence
催产素和促肾上腺皮质激素释放因子对酒精依赖的相反作用
- 批准号:
10451814 - 财政年份:2021
- 资助金额:
$ 66.71万 - 项目类别:
Opposing Contributions of Oxytocin and Corticotropin-Release Factor to Alcohol Dependence
催产素和促肾上腺皮质激素释放因子对酒精依赖的相反作用
- 批准号:
10655413 - 财政年份:2021
- 资助金额:
$ 66.71万 - 项目类别: